Financials

Discussions Technicals Seasonals

089140 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to NEXTURNBIOSCIENCE operating, investing, and financing activities

089140 free cash flow for Q2 24 is -3.09 B KRW. For 2023, 089140 free cash flow was -3.05 B KRW and operating cash flow was -1.97 B KRW.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—